Search results
Found 17940 matches for
The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.